Clinical Trial Update: Exenatide for Stress Hyperglycemia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update for exenatide in stress hyperglycemia has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Hyperglycemia

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Stress Hyperglycemia | Phase 2, Phase 3 | Status: COMPLETED